Core Insights - The ultraviolet resonance Raman spectrometer (UVRRS) is a high-end research instrument that enhances signals and avoids fluorescence interference, playing a crucial role in advancing fundamental research in materials and biochemistry [1][6] - The market size for China's UVRRS industry is projected to reach approximately 459 million yuan in 2024, representing a year-on-year growth of 13.33% [6] Industry Overview - UVRRS operates on the principle of resonance Raman effect, utilizing ultraviolet light (e.g., 266nm, 248nm) as an excitation source, significantly enhancing Raman signals while suppressing fluorescence background interference [2][3] - The technology is applicable in various research areas, including biomolecules, catalysts, and nanomaterials, enabling precise analysis of molecular structures and dynamics [2] Industry Development History - The development of China's UVRRS industry has gone through four stages: initial development in the 1970s-80s, breakthroughs in the 1990s to early 2000s, rapid growth from the early 2000s to 2015, and maturity and industrialization from 2016 to present [3][4] - Key milestones include the first domestic UV Raman spectrometer developed in 1997 and the establishment of a joint laboratory with Beijing Zhuoli Hanguang in 2008, leading to commercial production [3][7] Market Size - The UVRRS is essential for advancing research in protein structure analysis, drug interactions, catalyst characterization, and defect analysis in new energy materials [6] - The projected market size for 2024 indicates a significant growth trajectory, reflecting the increasing demand for advanced research tools [6] Key Companies and Institutions - The Chinese Academy of Sciences Dalian Institute of Chemical Physics is a leading technology source, having developed the first domestic UV Raman spectrometer and achieved breakthroughs in deep ultraviolet Raman technology [7][9] - Beijing Zhuoli Hanguang Instrument Co., Ltd. is the leading domestic company in the UVRRS field, collaborating closely with the Dalian Institute to develop advanced systems and achieve commercial production [9][10] Industry Development Trends 1. **Technological Innovation and Performance Breakthroughs**: The industry is expected to focus on core technology innovations, enhancing device performance towards higher precision and intelligence, with potential integration of AI for real-time spectral analysis [11][12] 2. **Expansion of Application Fields**: As technology matures, UVRRS applications will extend into areas such as gene editing and environmental monitoring, with customized detection modules for specific materials [12][13] 3. **Domestic Replacement and Ecosystem Construction**: The industry aims to accelerate the localization of core components, with increasing domestic production rates for high-precision lasers and detectors, fostering a collaborative innovation ecosystem [13][14]

Core Insights - The scientific instrument industry is experiencing rapid growth driven by localization efforts from multinational companies and technological breakthroughs from domestic firms, with significant market opportunities emerging from national policies [1][2] Multinational Companies' Strategies - Multinational companies are deepening localization and transitioning high-end production lines to China, with notable examples including Shimadzu and Hitachi, which have achieved significant milestones in local production [5][6] - In 2025, Shimadzu celebrated its 150th anniversary and delivered its 10,000th domestic liquid chromatography instrument, while also acquiring a European electron microscope manufacturer for $678 million [5] - Agilent's revenue reached $6.95 billion in fiscal year 2025, marking a 6.7% increase, with its Shanghai manufacturing center recognized as a "lighthouse factory" by the World Economic Forum [7] Domestic Companies' Growth - Domestic companies are leveraging technological advancements and capital support to grow rapidly, with state-owned enterprises and new brands actively entering the market [2][12] - Shanghai Instrument Group and Beijing Instrument Group are examples of state-owned enterprises that are enhancing their capabilities and contributing to the domestic scientific instrument sector [12][13] Brand Partnerships and Market Dynamics - The industry is seeing an increase in brand partnerships, with 30 leading companies selected annually to enhance their brand power and industry leadership through collaboration with Instrument Information Network [3][34] - Companies like Four Seasons Instruments and Juneng Technology are emerging as key players, achieving significant market share and revenue growth through innovative products and strategic partnerships [17][18] Emerging Brands and Innovations - New brands such as Dunning Bio and Jiezhou Tongchuang are entering the market, focusing on high-quality products and innovative solutions to capture market attention [25][26] - The industry is witnessing a trend of companies investing heavily in R&D, with some allocating nearly 20% of their revenue to innovation, exemplified by Baode and Tianrui Instruments [23][24] Market Outlook - The scientific instrument industry is poised for continued growth, driven by domestic substitution trends and increasing competition among both multinational and local players [20][21] - The focus on high-end, intelligent development is expected to accelerate, with significant investments in technology and infrastructure to support this transition [1][2]

Core Viewpoint - In December, the CSI 300 index rose by 2.28%, while the public utility index fell by 2.46% and the environmental index decreased by 0.04%, with relative monthly returns of -4.74% and -2.32% respectively [2] Market Review - The public utility and environmental sectors ranked 27th and 19th among 31 primary industry categories in terms of growth [2] - Within the electricity sector, coal-fired power dropped by 5.17%, hydropower decreased by 3.08%, and new energy generation fell by 0.39% [2] - The water sector declined by 2.55%, and the gas sector saw a slight decrease of 0.18% [2] Important Events - The State Council issued the "Comprehensive Solid Waste Management Action Plan," aiming for significant improvements in solid waste management by 2030, including controlling historical waste stockpiles and increasing the annual comprehensive utilization of major solid waste to 4.5 billion tons [2] Investment Strategy - Public Utilities: - Coal and electricity prices are declining, maintaining reasonable profitability for coal-fired power; recommended companies include Huadian International and Shanghai Electric [4] - Continued government support for new energy development is expected to stabilize profitability; recommended companies include Longyuan Power and Three Gorges Energy [4] - Nuclear power companies are expected to maintain stable profitability; recommended companies include China National Nuclear Power and China General Nuclear Power [4] - High-dividend hydropower stocks are highlighted for their defensive attributes; recommended company is Yangtze Power [4] - Gas companies with capabilities in marine gas trade are recommended, such as Jiufeng Energy [4] - Companies advancing in clean energy equipment manufacturing, like Xizi Clean Energy, are also recommended [4] - Environmental Sector: - The water and waste incineration sectors are maturing, with improved free cash flow; recommended companies include China Everbright Environment and Shanghai Industrial Holdings [4] - The domestic scientific instrument market has significant potential for domestic substitution; recommended companies include Juguang Technology and Wanyi Technology [4] - The EU's SAF blending policy is expected to benefit the domestic waste oil recycling industry; recommended company is Shangaohuaneng [4] - The agricultural biomass power generation sector is seeing cost improvements due to falling straw prices; recommended company is Changqing Group [4]

Group 1 - The company, 聚光科技 (Juguang Technology), stated on its investor interaction platform that it does not have any products related to lens array technology [1]

一、回购公司股份的进展情况 证券代码：300203 证券简称：聚光科技 公告编号：2026-001 聚光科技（杭州）股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 聚光科技(杭州)股份有限公司(下称"公司")于2025年8月20日召开第五届 董事会第二次会议，审议通过了《关于回购公司股份方案的议案》。同意公司使 用自有资金和自筹资金，以集中竞价交易方式回购部分公司已在境内发行的人民 币普通股（A股）股票，并在未来适宜时机用于实施股权激励计划或员工持股计 划。本次回购资金总额不低于人民币10,000万元（含本数）且不超过人民币15,000 万元（含本数），回购价格不超过人民币29.50元/股（含），回购期限为自公司 董事会审议通过本次回购方案之日起12个月内。具体内容详见公司于2025年8月 20日、2025年8月27日分别在巨潮资讯网披露的《关于回购公司股份方案的公告》 （公告编号：2025-031）、《回购报告书》（公告编号：2025-037）。 公司已取得交通银行股份有限公司杭州浣纱支行出具的《交通银行股票回购 增 ...

没有虚假记载、误导性陈述或重大遗漏。 聚光科技（杭州）股份有限公司（以下简称"公司"）因通讯线路调整，对公 司传真号码进行了变更。具体变更情况如下： | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | | 传真号码 | 0571-85012008 | 0571-86696560 | 除上述事项变更外，公司投资者联系电话、办公地址、邮政编码及电子邮箱 等其他联系方式保持不变，请广大投资者留意。由此给广大投资者带来的不便， 敬请谅解。欢迎广大投资者通过上述渠道与公司沟通联系。 特此公告！ 证券代码：300203 证券简称：聚光科技 公告编号：2026-002 聚光科技（杭州）股份有限公司 聚光科技（杭州）股份有限公司 董事会 关于变更传真号码的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 二〇二六年一月五日 ...

Core Viewpoint - The "3i Award - Excellent New Products" has recognized a total of 429 outstanding new products over the past 20 years, highlighting the importance of innovation in the scientific instrument industry and its role in driving economic and technological advancement [1][4]. Group 1: Importance of Scientific Instruments - Technological innovation is a core driving force for economic and social development, with scientific instruments serving as critical tools for research and innovation [2]. - Advanced scientific instruments facilitate exploration in both fundamental and applied research, revealing natural laws and accelerating the development and commercialization of new technologies [2]. Group 2: Overview of the 3i Award - The "3i Award - Excellent New Products" was initiated in 2006 to objectively showcase innovative scientific instruments and encourage manufacturers to meet user needs [3]. - The award has gained significant recognition over 20 years, becoming one of the most authoritative awards in China's scientific instrument industry, with nominations from nearly 300 manufacturers and around 700 new products each year [3]. Group 3: Award Statistics - The award has a low winning ratio, with about 20% of nominated products receiving a nomination and less than 2% winning the Excellent New Product Award, enhancing the award's prestige [3]. - The top 10 companies recognized for their outstanding new products include Thermo Fisher (41 awards), Focused Photonics (24), Agilent (19), and others, reflecting their commitment to innovation in the Chinese scientific instrument market [5][6][7]. Group 4: Future Outlook - As of December 29, 2025, over 200 domestic and international instrument companies have submitted 529 new products for the 2024 and 2025 awards, indicating a vibrant and innovative industry [7]. - The application period for the "3i Award - Excellent New Products (2025)" will close on January 15, 2026, inviting manufacturers to participate in this significant event [7][9].

Core Viewpoint - The integration of embodied intelligence and scientific instruments is fundamentally transforming the work methods, skill requirements, and career prospects of professionals in research and testing fields, marking a new industrial revolution in the scientific instrument industry [2]. Group 1: Application Scenarios of Scientific Instrument Integration - In materials science, embodied intelligent robots can autonomously conduct material synthesis and performance testing, increasing synthesis efficiency by three times according to a case study from Science Robotics [3]. - In biomedical experiments, intelligent surgical robots developed by Stanford University can analyze patient data in real-time during surgeries, providing decision support for doctors [3]. - In environmental monitoring and geological exploration, embodied intelligent drones can autonomously perform data collection, with a study from UC Berkeley indicating a twofold increase in data collection efficiency [3]. - In physics research, intelligent robots can operate accelerator equipment and analyze experimental data in real-time, with a report from Nature Physics showing a 1.5 times increase in the speed of discovering new physical phenomena [4]. - In chemical research, embodied intelligence is used for laboratory automation and reaction control, with MIT developing intelligent laboratory systems capable of autonomous chemical synthesis and real-time adjustment of reaction conditions [4]. Group 2: Related Cases - The most common application of embodied intelligence in laboratories is robotic arms, with companies like Huixiang Technology collaborating with Agilent on successful automation systems for multiple chromatographic devices [5]. - A bionic dual-arm robot from Hunan University can autonomously complete sample identification and precise placement on medical spectrometers, transforming the analysis process into a fully automated operation [6]. - A dual-robot pre-treatment platform from South China University of Technology can automatically complete the sequential extraction of water samples, significantly improving efficiency and accuracy [6]. Group 3: Future of Embodied Intelligence and Scientific Instruments - Future laboratory robots are expected to evolve from mere execution to decision-making capabilities, understanding complex natural language commands and autonomously planning experimental steps [14]. - Collaborative research networks may emerge where various types of robots work together seamlessly under AI scheduling, enhancing the efficiency of research processes [14]. - The integration of specialized sensors and actuators may allow robots to perform precision tasks at the nanoscale, such as operating electron microscopes or manipulating single cells for analysis [15][16]. Group 4: Challenges and Recommendations - The core challenges in this technological revolution include precision and reliability, particularly in dexterous operations and understanding non-standard processes [17]. - There is a need for a standardized system to address safety issues related to embodied intelligence, including model safety and decision transparency [19]. - Establishing a national-level common dataset and evaluation standards is recommended to promote data sharing and industry standardization [19]. - The development of ethical guidelines for safety assessments and decision-making transparency in embodied intelligence robots is crucial for their deployment in service industries [20].

Core Viewpoint - The stock of 聚光科技 (Juguang Technology) has experienced fluctuations, with a recent decline of 2.05% and a year-to-date increase of 5.21%, indicating mixed market sentiment and performance [1][2]. Financial Performance - For the period from January to September 2025, 聚光科技 reported a revenue of 2.05 billion yuan, reflecting a year-on-year decrease of 11.10% [2]. - The company recorded a net profit attributable to shareholders of -62.34 million yuan, a significant decline of 152.98% compared to the previous year [2]. Stock Market Activity - As of December 30, the stock price was 15.76 yuan per share, with a market capitalization of 7.072 billion yuan [1]. - The trading volume showed a net outflow of 6.598 million yuan from main funds, with large orders accounting for 21.39% of purchases and 35.53% of sales [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased to 23,000, up by 13.30%, while the average circulating shares per person decreased by 11.74% to 19,483 shares [2][3]. - The top three circulating shareholders include Hong Kong Central Clearing Limited, which reduced its holdings by 5.1892 million shares, and Ruiyuan Growth Value Mixed A, which increased its holdings by 2.4209 million shares [3]. Business Overview - 聚光科技 specializes in the research, production, and sales of instruments and equipment for environmental monitoring, industrial process analysis, and laboratory instruments [1]. - The main revenue sources are: instruments, related software, and consumables (69.24%), operational services, testing services, and consulting services (16.42%), environmental equipment and engineering (10.46%), and others (3.87%) [1]. Dividend Information - Since its A-share listing, 聚光科技 has distributed a total of 630 million yuan in dividends, with 112 million yuan distributed over the past three years [3].

Group 1 - The core viewpoint of the news is that 聚光科技 (Juguang Technology) is experiencing a decline in stock performance and financial metrics, with significant changes in shareholder structure and financing activities [1][2][3]. Group 2 - On December 29, 聚光科技's stock fell by 2.13%, with a trading volume of 163 million yuan. The financing buy-in amount was 24.92 million yuan, while the financing repayment was 23.97 million yuan, resulting in a net financing buy of 0.95 million yuan. The total financing and securities balance reached 457 million yuan [1]. - As of September 30, the number of shareholders for 聚光科技 increased to 23,000, a rise of 13.30%, while the average circulating shares per person decreased by 11.74% to 19,483 shares [2]. - For the period from January to September 2025, 聚光科技 reported a revenue of 2.05 billion yuan, a year-on-year decrease of 11.10%, and a net profit attributable to shareholders of -62.34 million yuan, a significant decline of 152.98% [2]. - Since its A-share listing, 聚光科技 has distributed a total of 630 million yuan in dividends, with 112 million yuan distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders of 聚光科技 included Hong Kong Central Clearing Limited as the third-largest shareholder, holding 13.82 million shares, a decrease of 5.19 million shares from the previous period. Meanwhile, Ruiyuan Growth Value Mixed A increased its holdings by 2.42 million shares to 10.86 million shares [3].